- The older cancer survivor population is predicted to increase substantially, an estimated 42% over the next decade.
- Nature reports that draft guidelines for nanomedicine are being developed and that with hundreds of nanoproducts currently being tested in humans, the recommendations aim to safeguard trial participants.
- A Conversation with Dr. Jane Perlmutter about the Role of Advocates in Cancer Research.
- Open-access R&D could be one answer to drug industry woes.
- The New York Times takes on the controversy of prostate cancer screening.